Acute Lung InjuryRespiratory Distress Syndrome, AdultPulmonary EdemaRespiration, ArtificialLungLung InjuryBronchoalveolar Lavage FluidVentilator-Induced Lung InjuryTidal VolumePulmonary AlveoliSepsisPneumoniaPositive-Pressure RespirationExtravascular Lung WaterLipopolysaccharidesBlood-Air BarrierRespiratory MucosaHydrochloric AcidDisease Models, AnimalMice, Inbred C57BLCapillary PermeabilityNeutrophilsPulmonary Gas ExchangeRespiratory MechanicsPeroxidaseAPACHELung DiseasesNeutrophil InfiltrationHyperoxiaUteroglobinProne PositionBronchoalveolar LavageShock, HemorrhagicLiquid VentilationMacrophages, AlveolarOleic AcidHeterocyclic Compounds, 2-RingCritical IllnessIntensive Care UnitsInflammation MediatorsInflammationCritical CareLung ComplianceProtein CThrombomodulinNeutrophil ActivationInterleukin-1betaRespiratory Dead SpaceAcute DiseaseCytokinesHMGB1 ProteinEpithelial CellsRespiratory System AgentsBiological MarkersTransendothelial and Transepithelial MigrationAngiopoietin-2ShockBlood Gas AnalysisPulmonary Surfactant-Associated Protein DProspective StudiesElectric ImpedancePermeabilityInterleukin-8Interleukin-6Mice, KnockoutTumor Necrosis Factor-alphaRandom AllocationChemokine CXCL2Ventilators, MechanicalPulmonary CirculationSeverity of Illness IndexCohort StudiesMultiple Organ FailureOxygenReceptors, Interleukin-8BAdministration, InhalationEndotoxinsNicotinamide PhosphoribosyltransferaseAnti-Inflammatory AgentsToll-Like Receptor 4AirEarly DiagnosisPulmonary SurfactantsWounds and InjuriesTime FactorsRats, Sprague-DawleyEndothelial CellsReceptor, Adenosine A2ATreatment OutcomeSan FranciscoEnzyme-Linked Immunosorbent AssayCells, CulturedRespiratory InsufficiencyBody FluidsPulmonary AtelectasisTrauma Severity IndicesIntensive CareChemokinesPneumonia, Ventilator-AssociatedInclusion Bodies